Also trades as: BAY.WA (WSE) · $vol 0M · BAYN.SW (SIX) · $vol 0M · BAYNN.MX (MEX) · $vol 0M

$12.64

-0.09 (-0.71%)

Weekly Expected Move ±4.5%

$12 $12 $13 $13 $14

OTC · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 32 · $49.7B mcap · 982M float · 0.097% daily turnover · Short 34% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest

Income Trends

Revenue

$43.8B -6.1% ▼

5Y CAGR: +1.1%

Gross Profit

$25.9B +2.3% ▲

5Y CAGR: +3.1%

Operating Income

$6.7B +100.8% ▲

Net Income

-$3.5B -36.3% ▼

EPS (Diluted)

$-0.88 -36.2% ▼

EBITDA

$10.6B +20.1% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$44.1B	$50.7B	$47.6B	$46.6B	$43.8B
YoY Growth	+6.5%	+15.1%	-6.1%	-2.2%	-6.1%
Cost of Revenue	$16.8B	$19.9B	$19.7B	$21.3B	$17.9B
Gross Profit	$27.3B	$30.9B	$27.9B	$25.3B	$25.9B
Gross Margin	61.9%	60.8%	58.5%	54.4%	59.2%
R&D Expenses	$5.4B	$6.6B	$5.4B	$6.2B	$5.5B
SG&A Expenses	$15.3B	$16.9B	$14.9B	$15.9B	$13.7B
Operating Expenses	$20.4B	$23.5B	$27.9B	$22.0B	$19.2B
Operating Income	$7.0B	$6.3B	-$150M	$3.3B	$6.7B
Operating Margin	15.8%	12.3%	-0.3%	7.1%	15.3%
Interest Expense	$1.3B	$1.9B	$2.0B	$2.4B	$1.7B
Income Before Tax	$2.0B	$4.7B	-$1.6B	-$2.3B	-$3.0B
Tax Expense	$1.0B	$504M	$1.3B	$212M	$448M
Net Income	$1.0B	$4.2B	-$2.9B	-$2.6B	-$3.5B
Net Margin	2.3%	8.2%	-6.2%	-5.5%	-7.9%
EPS (Diluted)	$0.26	$1.06	$-0.75	$-0.65	$-0.88
EBITDA	$7.0B	$10.4B	$4.2B	$8.8B	$10.6B
Shares Outstanding	3.93B	3.93B	3.93B	3.93B	3.93B

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$10.0B	$11.7B	$13.7B	$10.7B	$9.7B	$11.3B	$13.6B	$10.9B
Cost of Revenue	$5.1B	$5.7B	$5.6B	$4.4B	$4.3B	$4.5B	$5.3B	$4.5B
Gross Profit	$4.9B	$6.0B	$8.1B	$6.4B	$5.4B	$6.9B	$8.3B	$6.3B
Gross Margin	48.9%	51.2%	59.1%	59.4%	55.4%	60.6%	61.0%	58.2%
R&D Expenses	$1.6B	$1.7B	$1.5B	$1.4B	$1.8B	$1.4B	$1.4B	$1.5B
SG&A Expenses	$3.7B	$4.3B	$3.7B	$3.5B	$3.4B	$3.8B	$3.7B	$4.0B
Operating Expenses	$9.3B	$2.5B	$5.8B	$6.4B	$5.9B	$5.2B	$5.1B	$5.5B
Operating Income	-$406M	$3.5B	$2.3B	$13M	-$543M	$1.7B	$3.2B	$891M
Operating Margin	-4.1%	30.1%	16.9%	0.1%	-5.6%	14.9%	23.2%	8.2%
Interest Expense	$642M	$385M	$584M	$561M	$890M	$669M	$690M	$622M
Income Before Tax	-$4.3B	-$481M	$1.8B	-$426M	-$1.2B	-$3.3B	$3.0B	$321M
Tax Expense	-$153M	-$153M	$526M	-$236M	-$202M	$374M	$226M	$92M
Net Income	-$4.2B	-$335M	$1.3B	-$199M	-$961M	-$3.7B	$2.8B	$219M
Net Margin	-42.0%	-2.9%	9.5%	-1.9%	-9.9%	-32.8%	20.6%	2.0%
EPS (Diluted)	$-1.06	$-0.09	$0.33	$-0.05	$-0.25	$-0.94	$0.71	$0.06
EBITDA	$1.1B	$1.7B	$3.6B	$236M	$606M	$2.0B	$4.4B	$2.2B
Shares Outstanding	3.93B	3.93B	3.93B	3.93B	3.93B	3.93B	3.93B	3.93B

BAYRY OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet